相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Fibromyalgia in Axial Spondyloarthritis A Meta-analysis
Seung Min Son et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2022)
Safety and Efficacy of Upadacitinib in Patients With Active Ankylosing Spondylitis and an Inadequate Response to Nonsteroidal Antiinflammatory Drug Therapy: One-Year Results of a Double-Blind, Placebo-Controlled Study and Open-Label Extension
Atul Deodhar et al.
ARTHRITIS & RHEUMATOLOGY (2022)
Tumor Necrosis Factor Inhibitor Dose Reduction for Axial Spondyloarthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Daeria O. Lawson et al.
ARTHRITIS CARE & RESEARCH (2021)
Improvement of Signs and Symptoms of Nonradiographic Axial Spondyloarthritis in Patients Treated With Secukinumab: Primary Results of a Randomized, Placebo-Controlled Phase III Study
Atul Deodhar et al.
ARTHRITIS & RHEUMATOLOGY (2021)
Use of IL-23 Inhibitors for the Treatment of Plaque Psoriasis and Psoriatic Arthritis: A Comprehensive Review
Kevin Yang et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2021)
Continuing versus withdrawing ixekizumab treatment in patients with axial spondyloarthritis who achieved remission: efficacy and safety results from a placebo-controlled, randomised withdrawal study (COAST-Y)
Robert B. M. Landewe et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled study
Atul Deodhar et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial
Anna Molto et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
Nonsteroidal Antiinflammatory Drug Use and Association With Incident Hypertension in Ankylosing Spondylitis
Jean W. Liew et al.
ARTHRITIS CARE & RESEARCH (2020)
Comparison of the Effects of Secukinumab and Adalimumab Biosimilar on Radiographic Progression in Patients with Ankylosing Spondylitis: Design of a Randomized, Phase IIIb Study (SURPASS)
Xenofon Baraliakos et al.
CLINICAL DRUG INVESTIGATION (2020)
Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial
Atul Deodhar et al.
LANCET (2020)
Predicting response to anti-TNFα therapy among patients with axial spondyloarthritis (axSpA): results from BSRBR-AS
Gary J. Macfarlane et al.
RHEUMATOLOGY (2020)
Physical activity and sedentary behaviour and their associations with clinical measures in axial spondyloarthritis
Elaine H. Coulter et al.
RHEUMATOLOGY INTERNATIONAL (2020)
Maintenance of clinical remission in early axial spondyloarthritis following certolizumab pegol dose reduction
Robert B. M. Landewe et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase IIb, randomised, double-blind, placebo-controlled, dose-ranging study
Desiree van der Heijde et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Effect of Therapy on Radiographic Progression in Axial Spondyloarthritis: A Systematic Review and Meta-Analysis
Paras Karmacharya et al.
ARTHRITIS & RHEUMATOLOGY (2020)
Effect of biologic disease-modifying anti-rheumatic drugs targeting remission in axial spondyloarthritis: systematic review and meta-analysis
Ana Rita Cruz-Machado et al.
RHEUMATOLOGY (2020)
Unmet needs in ankylosing spondylitis patients receiving tumour necrosis factor inhibitor therapy; results from a large multinational real-world study
A. Deodhar et al.
BMC RHEUMATOLOGY (2020)
Effectiveness of switching between TNF inhibitors in patients with axial spondyloarthritis: is the reason to switch relevant?
Santiago Rodrigues Manica et al.
ARTHRITIS RESEARCH & THERAPY (2020)
Patient-reported Disease Activity in an Axial Spondyloarthritis Cohort during the COVID-19 Pandemic
Jean W. Liew et al.
ACR OPEN RHEUMATOLOGY (2020)
ETANERCEPT WITHDRAWAL AND RE-TREATMENT IN PATIENTS WITH INACTIVE NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS AT 24 WEEKS: RESULTS OF RE-EMBARK, AN OPEN-LABEL, PHASE IV TRIAL
F. Van den Bosch et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
CLUSTER-RANDOMIZED PRAGMATIC CLINICAL TRIAL EVALUATING THE POTENTIAL BENEFIT OF A TIGHT-CONTROL AND TREAT-TO-TARGET STRATEGY IN AXIAL SPONDYLOARTHRITIS: THE RESULTS OF THE TICOSPA TRIAL.
A. Molto et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
A Fifty-Two-Week, Randomized, Placebo-Controlled Trial of Certolizumab Pegol in Nonradiographic Axial Spondyloarthritis
Atul Deodhar et al.
ARTHRITIS & RHEUMATOLOGY (2019)
The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies
Dennis G. McGonagle et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis
Michael M. Ward et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Three Multicenter, Randomized, Double-Blind, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis
Atul Deodhar et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Why did IL-23p19 inhibition fail in AS: a tale of tissues, trials or translation?
Stefan Siebert et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
The Safety Profile of Tumor Necrosis Factor Inhibitors in Ankylosing Spondylitis: Are TNF Inhibitors Safer Than We Thought?
Jakub Wronski et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Secukinumab shows sustained efficacy and low structural progression in ankylosing spondylitis: 4-year results from the MEASURE 1 study
Juergen Braun et al.
RHEUMATOLOGY (2019)
Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trial
Desiree van der Heijde et al.
LANCET (2019)
Efficacy and Safety of Ixekizumab in the Treatment of Radiographic Axial Spondyloarthritis: Sixteen-Week Results From a Phase III Randomized, Double-Blind, Placebo-Controlled Trial in Patients With Prior Inadequate Response to or Intolerance of Tumor Necrosis Factor Inhibitors
Atul Deodhar et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Spinal radiographic progression over 2years in ankylosing spondylitis patients treated with secukinumab: a historical cohort comparison
J. Braun et al.
ARTHRITIS RESEARCH & THERAPY (2019)
Long-term safety of secukinumab in patients with moderate-to-severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis: integrated pooled clinical trial and post-marketing surveillance data
A. Deodhar et al.
ARTHRITIS RESEARCH & THERAPY (2019)
Limited radiographic progression and sustained reductions in MRI inflammation in patients with axial spondyloarthritis: 4-year imaging outcomes from the RAPID-axSpA phase III randomised trial
Desiree van der Heijde et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Efficacy and safety of continuing versus withdrawing adalimumab therapy in maintaining remission in patients with non-radiographic axial spondyloarthritis (ABILITY-3): a multicentre, randomised, double-blind study
Robert Landewe et al.
LANCET (2018)
Lights and shadows of NSAIDs in bone healing: the role of prostaglandins in bone metabolism
Barbara Lisowska et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2018)
Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study
Dominique Baeten et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological diseasemodifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial
Desiree van der Heijde et al.
LANCET (2018)
Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial
Desiree van der Heijde et al.
LANCET (2018)
TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort
Christoph Molnar et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Efficacy and Safety of Secukinumab 150 mg with and Without Loading Regimen in Ankylosing Spondylitis: 104-week Results from MEASURE 4 Study
Alan J. Kivitz et al.
RHEUMATOLOGY AND THERAPY (2018)
The Effectiveness of Structured Group Education on Ankylosing Spondylitis Patients
Meliha Kasapoglu Aksoy et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2017)
Switching tumor necrosis factor inhibitors in the treatment of axial spondyloarthritis
Atul Deodhar et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2017)
Reduction in Spinal Radiographic Progression in Ankylosing Spondylitis Patients Receiving Prolonged Treatment With Tumor Necrosis Factor Inhibitors
Fiona Maas et al.
ARTHRITIS CARE & RESEARCH (2017)
Treat to Target in Axial Spondyloarthritis: What Are the Issues?
Abhijeet Danve et al.
CURRENT RHEUMATOLOGY REPORTS (2017)
Efficacy, safety, and tolerability of secukinumab in patients with active ankylosing spondylitis: a randomized, double-blind phase 3 study, MEASURE 3
Karel Pavelka et al.
ARTHRITIS RESEARCH & THERAPY (2017)
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis
Desiree van der Heijde et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Effect of continuous versus on-demand treatment of ankylosing spondylitis with diclofenac over 2 years on radiographic progression of the spine: results from a randomised multicentre trial (ENRADAS)
Joachim Sieper et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis
Michael M. Ward et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Physical activity in patients with axial spondyloarthritis: a cross-sectional study of 203 patients
Stephanie Fabre et al.
RHEUMATOLOGY INTERNATIONAL (2016)
Benefit of health education by a training nurse in patients with axial and/or peripheral psoriatic arthritis: A systematic literature review
G. Candelas et al.
RHEUMATOLOGY INTERNATIONAL (2016)
The Effect of Comedication With a Conventional Synthetic Disease-Modifying Antirheumatic Drug on Drug Retention and Clinical Effectiveness of Anti-Tumor Necrosis Factor Therapy in Patients With Axial Spondyloarthritis
Michael J. Nissen et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Rate and Predisposing Factors for Sacroiliac Joint Radiographic Progression After a Two-Year Follow-up Period in Recent-Onset Spondyloarthritis
Maxime Dougados et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Effect of Comedication With Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Retention of Tumor Necrosis Factor Inhibitors in Patients With Spondyloarthritis: A Prospective Cohort Study
A. Sepriano et al.
ARTHRITIS & RHEUMATOLOGY (2016)
Clinical improvement and reduction in serum calprotectin levels after an intensive exercise programme for patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis
Andrea Levitova et al.
ARTHRITIS RESEARCH & THERAPY (2016)
Patients With Ankylosing Spondylitis Have Increased Cardiovascular and Cerebrovascular Mortality A Population-Based Study
Nisha Nigil Haroon et al.
ANNALS OF INTERNAL MEDICINE (2015)
The effect of comedication with conventional synthetic disease modifying antirheumatic drugs on TNF inhibitor drug survival in patients with ankylosing spondylitis and undifferentiated spondyloarthritis: results from a nationwide prospective study
Elisabeth Lie et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Predictors of Clinical Remission under Anti-tumor Necrosis Factor Treatment in Patients with Ankylosing Spondylitis: Pooled Analysis from Large Randomized Clinical Trials
Xenofon Baraliakos et al.
JOURNAL OF RHEUMATOLOGY (2015)
Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis
Dominique Baeten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
A Randomized, Double-Blind, Placebo-Controlled, Sixteen-Week Study of Subcutaneous Golimumab in Patients With Active Nonradiographic Axial Spondyloarthritis
J. Sieper et al.
ARTHRITIS & RHEUMATOLOGY (2015)
TNF-alpha inhibitors for ankylosing spondylitis
Lara J. Maxwell et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2015)
Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis)
Feline P. B. Kroon et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2015)
Predictors of response to TNF antagonists in patients with ankylosing spondylitis and psoriatic arthritis: systematic review and meta-analysis
Jose Ramon Maneiro et al.
RMD OPEN (2015)
Efficacy of certolizumab pegol on signs and symptoms of axial spondyloarthritis including ankylosing spondylitis: 24-week results of a double-blind randomised placebo-controlled Phase 3 study
R. Landewe et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Exercise therapy for spondyloarthritis: a systematic review
Tom O'Dwyer et al.
RHEUMATOLOGY INTERNATIONAL (2014)
Symptomatic Efficacy of Etanercept and Its Effects on Objective Signs of Inflammation in Early Nonradiographic Axial Spondyloarthritis A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
Maxime Dougados et al.
ARTHRITIS & RHEUMATOLOGY (2014)
The Interleukin-23/Interleukin-17 Axis in Spondyloarthritis Pathogenesis Th17 and Beyond
Judith A. Smith et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Efficacy and safety of adalimumab in patients with non-radiographic axial spondyloarthritis: results of a randomised placebo-controlled trial (ABILITY-1)
Joachim Sieper et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials
N. Bhala et al.
LANCET (2013)
Continuous NSAID use reverts the effects of in ammation on radiographic progression in patients with ankylosing spondylitis
Feline Kroon et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
On the impact of a dedicated educational program for ankylosing spondylitis: Effect on patient satisfaction, disease knowledge and spinal mobility, a pilot study
Anne Sudre et al.
JOINT BONE SPINE (2012)
Obstructive sleep apnea and the risk of autoimmune diseases: A longitudinal population-based study
Jiunn-Horng Kang et al.
SLEEP MEDICINE (2012)
Predicting the outcome of ankylosing spondylitis therapy
Nathan Vastesaeger et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Analysis of IL-17(+) cells in facet joints of patients with spondyloarthritis suggests that the innate immune pathway might be of greater relevance than the Th17-mediated adaptive immune response
Heiner Appel et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Exercise in Ankylosing Spondylitis: Discrepancies Between Recommendations and Reality
Laura A. Passalent et al.
JOURNAL OF RHEUMATOLOGY (2010)
Nonsteroidal Anti-inflammatory Drugs for Prophylaxis of Acute Anterior Uveitis
Ralph D. Levinson et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2010)
The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection
M. Rudwaleit et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
A protective function for interleukin 17A in T cell-mediated intestinal inflammation
William O'Connor et al.
NATURE IMMUNOLOGY (2009)
Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years
Desiree van der Heijde et al.
ARTHRITIS RESEARCH & THERAPY (2009)
The comparative one-year performance of anti-tumor necrosis factor α drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis:: Results from a longitudinal, observational, multicenter study
Marte Schrumpf Heiberg et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Efficacy and Safety of Golimumab in Patients With Ankylosing Spondylitis Results of a Randomized, Double-Blind, Placebo-Controlled, Phase III Trial
Robert D. Inman et al.
ARTHRITIS AND RHEUMATISM (2008)
Radiographic Findings Following Two Years of Infliximab Therapy in Patients With Ankylosing Spondylitis
Desiree van der Heijde et al.
ARTHRITIS AND RHEUMATISM (2008)
Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept
D. van der Heijde et al.
ARTHRITIS AND RHEUMATISM (2008)
Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants
Melanie Newport et al.
NATURE GENETICS (2007)
Serum IL-17, BMP-7, and bone turnover markers in patients with ankylosing spondylitis
Daniel Wendling et al.
JOINT BONE SPINE (2007)
No efficacy of subcutaneous methotrexate in active ankylosing spondylitis: a 16-week open-label trial
H. Haibel et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Nonsteroidal anti-inflammatory drug use in ankylosing spondylitis -: a population-based survey
Jane Zochling et al.
CLINICAL RHEUMATOLOGY (2006)
Efficacy and safety of adalimumab in patients with ankylosing spondylitis - Results of a multicenter, randomized, double-blind, placebo-controlled trial
Desiree van der Heijde et al.
ARTHRITIS AND RHEUMATISM (2006)
Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis -: A randomized clinical trial
A Wanders et al.
ARTHRITIS AND RHEUMATISM (2005)
Efficacy and safety of infliximab in patients with ankylosing spondylitis - Results of a randomized, placebo-controlled trial (ASSERT)
D van der Heijde et al.
ARTHRITIS AND RHEUMATISM (2005)
Recombinant human tumor necrosis factor receptor, (etanercept) for treating ankylosing spondylitis - A randomized, controlled trial
JC Davis et al.
ARTHRITIS AND RHEUMATISM (2003)
Treatment of active ankylosing spondylitis with pamidronate
H Haibel et al.
RHEUMATOLOGY (2003)
Employment, work disability, and work days lost in patients with ankylosing spondylitis: a cross sectional study of Dutch patients
A Boonen et al.
ANNALS OF THE RHEUMATIC DISEASES (2001)
分享论文
